|
Final Agenda Stakeholder Event on Biosimilar Medicinal Products - 14/09/2018
Data documentului: Thu Sep 13 00:00:00 CEST 2018
- Creat de GROW.DDG1.D.DIR
- Data publicării: Mon Sep 17 15:19:50 CEST 2018
- Ultima actualizare: Mon Sep 17 15:20:02 CEST 2018
|
|
Improving understanding of biosimilars across the EU
Data documentului: Thu Sep 13 00:00:00 CEST 2018
- Creat de GROW.DDG1.D.DIR
- Data publicării: Fri Sep 28 16:16:22 CEST 2018
- Ultima actualizare: Fri Sep 28 16:16:34 CEST 2018
|
|
Biosimilars in the EU - Information guide for healthcare professionals
Data documentului: Wed Apr 26 00:00:00 CEST 2017
- Creat de GROW.DDG1.D.1
- Data publicării: Wed May 03 10:10:13 CEST 2017
- Ultima actualizare: Wed May 03 10:10:33 CEST 2017
|
|
EC Stakeholder Workshop on Biosimilars 5 May 2017 final draft agenda
Data documentului: Mon Apr 24 00:00:00 CEST 2017
- Creat de GROW.DDG1.D.1
- Data publicării: Thu May 04 14:00:43 CEST 2017
- Ultima actualizare: Thu May 04 14:01:00 CEST 2017
|
|
CHMP scientific opinion on the principal mode of action of proanthocyanidins intended to be used for prevention and treatment of urinary tract infections - Art. 57(1) of Regulation (EC) No 726/2004
Data documentului: Thu Jul 21 00:00:00 CEST 2016
- Creat de GROW.DDG1.D.4
- Data publicării: Tue Nov 15 10:26:10 CET 2016
- Ultima actualizare: Tue Nov 15 10:27:01 CET 2016
|
